Inventor · disambiguated record
Allison L. Zulli
Also filed as: ZULLI ALLISON · ZULLI ALLISON L
29 granted patents·8 pending applications·111 citations·filing 2004–2024
96Inventor score
Top patents by PatentIndex Score
37 records- 0195US11702388B21,4-substituted piperidine derivatives89BIO LTD·Filed 2020·Granted Jul 18, 2023·3 cites·20 claims
- 0293US10851057B21,4-substituted piperidine derivatives89BIO LTD·Filed 2019·Granted Dec 1, 2020·5 cites·16 claims
- 0390US10221135B21,4-substituted piperidine derivatives89BIO LTD·Filed 2018·Granted Mar 5, 2019·7 cites·30 claims
- 0490US9902696B21,4-substituted piperidine derivativesCEPHALON INC·Filed 2016·Granted Feb 27, 2018·7 cites·21 claims
- 0589US11046707B2Spiropiperidine derivatives89BIO LTD·Filed 2017·Granted Jun 29, 2021·4 cites·16 claims
- 0687US2025257035A11,4-Substituted Piperidine DerivativesCEPHALON LLC·Filed 2024·Application pending·0 cites
- 0786US12098130B21,4-substituted piperidine derivatives89BIO LTD·Filed 2023·Granted Sep 24, 2024·0 cites·18 claims
- 0885US8673916B2Methods of treating disorders mediated by histamine H3 receptors using pyridazinone derivativesBACON EDWARD R·Filed 2011·Granted Mar 18, 2014·7 cites·21 claims
- 0985US7671064B2Fused pyrrolocarbazolesCEPHALON INC·Filed 2006·Granted Mar 2, 2010·7 cites·33 claims
- 1084US12448392B2Spiropiperidine derivatives89BIO LTD·Filed 2023·Granted Oct 21, 2025·0 cites·18 claims
- 1184US10464952B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2018·Granted Nov 5, 2019·5 cites·13 claims
- 1284US7169802B2Fused pyrrolocarbazolesCEPHALON INC·Filed 2004·Granted Jan 30, 2007·18 cites·21 claims
- 1382US9914730B2Azaquinazoline inhibitors of Atypical protein Kinase CIGNYTA INC·Filed 2013·Granted Mar 13, 2018·6 cites·13 claims
- 1482US9896446B2Azaquinazoline inhibitors of atypical protein kinase CIGNYTA INC·Filed 2015·Granted Feb 20, 2018·4 cites·14 claims
- 1582US8513232B2Substituted spirocyclic piperidine derivatives as histamine-3 (H3) receptor ligandsBACON EDWARD R·Filed 2010·Granted Aug 20, 2013·9 cites·30 claims
- 1681US7241779B2Fused pyrrolocarbazolesCEPHALON INC·Filed 2004·Granted Jul 10, 2007·13 cites·21 claims
- 1779US8207168B2Pyridazinone derivativesBECKNELL NADINE C·Filed 2010·Granted Jun 26, 2012·5 cites·20 claims
- 1878US8247414B2Pyridizinone derivatives and the use thereof as H3 inhibitorsBACON EDWARD R·Filed 2007·Granted Aug 21, 2012·2 cites·37 claims
- 1976US8044064B2Fused pyrrolocarbazolesCEPHALON INC·Filed 2010·Granted Oct 25, 2011·2 cites·10 claims
- 2075US8716493B2Multicyclic compounds and the use thereofCHATTERJEE SANKAR·Filed 2010·Granted May 6, 2014·4 cites·27 claims
- 2175US8586588B2Aryl pyridazinone derivatives and their use as H3 receptor ligandsBACON EDWARD R·Filed 2010·Granted Nov 19, 2013·2 cites·27 claims
- 2273US11878982B2Spiropiperidine derivatives89BIO LTD·Filed 2021·Granted Jan 23, 2024·0 cites·2 claims
- 2368US8648067B2Substituted phenoxypropylcycloamine derivatives as histamine-3 (H3) receptor ligandsBACON EDWARD R·Filed 2011·Granted Feb 11, 2014·1 cites·21 claims
- 2464US9914731B2Pyrazolo[1,5-a]pyridine derivatives and methods of their useIGNYTA INC·Filed 2014·Granted Mar 13, 2018·0 cites·18 claims
- 2559US8084472B2Fused pyrrolocarbazolesHUDKINS ROBERT L·Filed 2009·Granted Dec 27, 2011·0 cites·16 claims
- 2658US7514440B2Fused pyrrolocarbazolesCEPHALON INC·Filed 2007·Granted Apr 7, 2009·0 cites·14 claims
- 2758US2024270762A1Penicillin-binding protein inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2857US8383813B2Fused pyrrolocarbazolesCEPHALON INC·Filed 2011·Granted Feb 26, 2013·0 cites·2 claims
- 2956US2018148447A1Pyrazolo[1,5-a]pyridine derivatives and methods of their useIGNYTA INC·Filed 2018·Application pending·0 cites
- 3051US2006276497A1Novel multicyclic compounds and the use thereofCEPHALON INC·Filed 2006·Application pending·0 cites
- 3151US2023114728A1Penicillin-binding protein inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3250US2014296212A1Substituted phenoxypropylcycloamine derivatives as histamine-3 (h3) receptor ligandsBACON EDWARD R·Filed 2014·Application pending·0 cites
- 3349US2022194964A1Solid forms of an orally-delivered beta-lactamase inhibitor and uses thereofVENATORX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3445US12173018B2Penicillin-binding protein inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2019·Granted Dec 24, 2024·0 cites·17 claims
- 3541US11332485B2Penicillin-binding protein inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2018·Granted May 17, 2022·0 cites·16 claims
- 3637US2011098269A1Substituted Pyridazinone Derivatives as Histamine-3 (H3) Receptor LigandsCEPHALON INC·Filed 2010·Application pending·0 cites
- 3732US10414763B2Azaquinazoline inhibitors of atypical protein kinase CCANCER RESEARCH TECH LTD·Filed 2015·Granted Sep 17, 2019·0 cites·29 claims
Join the waitlist — get patent alerts
Get an alert when Allison L. Zulli files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →